Peptide stability is influenced by several factors
In 2017, the Food and Drug Administration (FDA) approved Ozempic, which contains semaglutide as the main active ingredient, as a treatment for type 2 diabetes
10.6118/jmm.2015.21.2.93 [DOI] [PMC free article] [PubMed] [Google Scholar] Li Y., Fu H., Wang H., Luo S., Wang L., Chen J., et al
Tirzepatide works by mimicking glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, hormones that regulate blood sugar and satiety across a 24-hour cycle
Thus, based on the market analysis, the rise in the stringent regulatory standards hinders the L-carnitine market demand
We identified dissolved oxygen and contaminating metal ions as the primary factors responsible for this loss of activity